000 01314 a2200313 4500
005 20250517145008.0
264 0 _c20180410
008 201804s 0 0 eng d
022 _a1473-0782
024 7 _a10.1080/13625187.2017.1305349
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCagnacci, Angelo
245 0 0 _aHormonal contraception: venous and arterial disease.
_h[electronic resource]
260 _bThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
_cJun 2017
300 _a191-199 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAndrostenes
_xadverse effects
650 0 4 _aAtherosclerosis
_xchemically induced
650 0 4 _aContraceptives, Oral, Synthetic
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevonorgestrel
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aRisk Factors
650 0 4 _aVenous Thromboembolism
_xchemically induced
773 0 _tThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
_gvol. 22
_gno. 3
_gp. 191-199
856 4 0 _uhttps://doi.org/10.1080/13625187.2017.1305349
_zAvailable from publisher's website
999 _c27024014
_d27024014